{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:33:18Z","timestamp":1761708798190},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Burns"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.burns.2012.07.018","type":"journal-article","created":{"date-parts":[[2012,8,24]],"date-time":"2012-08-24T02:30:15Z","timestamp":1345775415000},"page":"326-330","source":"Crossref","is-referenced-by-count":9,"title":["Evaluation of the effects of resveratrol and bevacizumab on experimental corneal alkali burn"],"prefix":"10.1016","volume":"39","author":[{"given":"Selim","family":"Doganay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Penpe Gul","family":"Firat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cem","family":"Cankaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hale","family":"Kirimlioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.burns.2012.07.018_bib0005","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0039-6257(98)00035-6","article-title":"Ocular neovascularization: an epidemiologic review","volume":"43","author":"Lee","year":"1998","journal-title":"Surv Ophthalmol"},{"issue":"4","key":"10.1016\/j.burns.2012.07.018_bib0010","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00055735-200108000-00002","article-title":"Corneal neovascularization","volume":"12","author":"Chang","year":"2001","journal-title":"Curr Opin Ophthalmol"},{"issue":"4","key":"10.1016\/j.burns.2012.07.018_bib0015","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/00003226-198706040-00004","article-title":"Corneal neovascularization. Pathogenesis and inhibition","volume":"6","author":"Epstein","year":"1987","journal-title":"Cornea"},{"issue":"2","key":"10.1016\/j.burns.2012.07.018_bib0020","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00417-005-0036-1","article-title":"Inhibitory effect of triamcinolone acetonide on corneal neovascularization","volume":"244","author":"Murata","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"11","key":"10.1016\/j.burns.2012.07.018_bib0025","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1007\/s004170050387","article-title":"Topikal application of methotrexate for inhibition of corneal angiogenesis","volume":"237","author":"Joussen","year":"1999","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"8","key":"10.1016\/j.burns.2012.07.018_bib0030","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1167\/iovs.05-1425","article-title":"Sustained intraocular rapamycin delivery effectively prevents high risk corneal allograft rejection and neovascularization in rabbits","volume":"47","author":"Shi","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.burns.2012.07.018_bib0035","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1600-0420.2004.00312.x","article-title":"Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in the regulation of corneal neovascularization and wound healing","volume":"82","author":"Gan","year":"2004","journal-title":"Acta Ophthalmol Scand"},{"issue":"9","key":"10.1016\/j.burns.2012.07.018_bib0040","first-page":"2514","article-title":"Expression of vascular endothelial factor and its receptors in inflamed and vacularized human corneas","volume":"41","author":"Philipp","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.burns.2012.07.018_bib0045","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00006982-200502000-00001","article-title":"The role of vascular endothelial growth factor in ocular health and disease","volume":"25","author":"Adamis","year":"2005","journal-title":"Retina"},{"issue":"4","key":"10.1016\/j.burns.2012.07.018_bib0050","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1345\/aph.1H316","article-title":"Bevacizumab for neovascular ocular diseases","volume":"41","author":"Lynch","year":"2007","journal-title":"Ann Pharmacother"},{"issue":"4","key":"10.1016\/j.burns.2012.07.018_bib0055","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1089\/jop.2007.0012","article-title":"Short-term results of intravitreal bevacizumab for macular edema with retinal vein obstruction and diabetic macular edema","volume":"23","author":"Byeon","year":"2007","journal-title":"J Ocul Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.burns.2012.07.018_bib0060","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/00006982-200604000-00001","article-title":"Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration","volume":"26","author":"Spaide","year":"2006","journal-title":"Retina"},{"issue":"2","key":"10.1016\/j.burns.2012.07.018_bib0065","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3928\/1542-8877-20060301-11","article-title":"Intravitreal bevacizumab in a patient with neovascular glaucoma","volume":"37","author":"Kahook","year":"2006","journal-title":"Ophthalmic Surg Lasers Imaging"},{"issue":"3","key":"10.1016\/j.burns.2012.07.018_bib0070","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/00006982-200603000-00018","article-title":"Intravitreal bevacizumab (Avastin) for refractory pseudophakic cystoid macular edema","volume":"26","author":"Mason","year":"2006","journal-title":"Retina"},{"issue":"Suppl. 1","key":"10.1016\/j.burns.2012.07.018_bib0075","first-page":"51","article-title":"Nutracetical as anti-angiogenic agents, hopes and reality","volume":"56","author":"Dulak","year":"2005","journal-title":"J Physiol Pharmacol"},{"issue":"10","key":"10.1016\/j.burns.2012.07.018_bib0080","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1096\/fj.01-0028fje","article-title":"Suppression of angiogenesis, tumour growth, and wound healing by resveratrol, a natural compound in red wine and grapes","volume":"15","author":"Br\u00e5kenhielm","year":"2001","journal-title":"FASEB J"},{"issue":"1","key":"10.1016\/j.burns.2012.07.018_bib0085","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00417-002-0591-7","article-title":"Inhibition of experimental angiogenesis of cornea by somatostatin","volume":"241","author":"Wu","year":"2003","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"10.1016\/j.burns.2012.07.018_bib0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1350-9462(02)00043-5","article-title":"Vascular endothelial growth factors and angiogenesis in eye disease","volume":"22","author":"Witmer","year":"2003","journal-title":"Prog Retin Eye Res"},{"issue":"12","key":"10.1016\/j.burns.2012.07.018_bib0095","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1136\/bjo.2006.098426","article-title":"Vascular endothelial growth factor biology, clinical implications for ocular treatments","volume":"90","author":"Bhisitkul","year":"2006","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"10.1016\/j.burns.2012.07.018_bib0100","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1161\/01.CIR.93.8.1493","article-title":"Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3","volume":"93","author":"Vincenti","year":"1996","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.burns.2012.07.018_bib0105","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.yexcr.2005.11.008","article-title":"VEGF function in vascular pathogenesis","volume":"312","author":"Ng","year":"2006","journal-title":"Exp Cell Res"},{"issue":"3","key":"10.1016\/j.burns.2012.07.018_bib0110","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/02713680600559564","article-title":"Experimental inhibition of corneal neovascularization by photodynamic therapy with verteporfin","volume":"31","author":"Yoon","year":"2006","journal-title":"Curr Eye Res"},{"issue":"4","key":"10.1016\/j.burns.2012.07.018_bib0115","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3928\/1542-8877-20050701-14","article-title":"Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration","volume":"36","author":"Rosenfeld","year":"2005","journal-title":"Ophthalmic Surg Lasers Imaging"},{"issue":"8","key":"10.1016\/j.burns.2012.07.018_bib0120","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1442-9071.2007.01572.x","article-title":"Bevacizumab inhibits corneal neovascularization in an alkali burn induced model of corneal angiogenesis","volume":"35","author":"Hosseini","year":"2007","journal-title":"Clin Experiment Ophthalmol"},{"issue":"3","key":"10.1016\/j.burns.2012.07.018_bib0125","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ajo.2007.11.003","article-title":"Inhibition of corneal neovascularization by subconjunctival bevacizumab in an animal model","volume":"145","author":"Papathanassiou","year":"2008","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.burns.2012.07.018_bib0130","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00417-007-0684-4","article-title":"Bevacizumab (Avastin) eye drops inhibit corneal neovascularization","volume":"246","author":"Bock","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"10.1016\/j.burns.2012.07.018_bib0135","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/bjo.2006.107912","article-title":"Inhibition of experimental corneal neovascularization by Bevacizumab (AVASTIN)","volume":"91","author":"Manzano","year":"2007","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.burns.2012.07.018_bib0140","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/ICO.0b013e318160d019","article-title":"Effect of subconjunctival bevacizumab (Avastin) on experimental corneal neovascularization in guinea pigs","volume":"27","author":"Hurmeric","year":"2008","journal-title":"Cornea"},{"issue":"8","key":"10.1016\/j.burns.2012.07.018_bib0145","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/carcin\/22.8.1111","article-title":"A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol","volume":"22","author":"Gusman","year":"2001","journal-title":"Carcinogenesis"},{"issue":"2","key":"10.1016\/j.burns.2012.07.018_bib0150","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/02713680500514685","article-title":"The effect of resveratrol in experimental cataract model formed by sodium selenite","volume":"31","author":"Doganay","year":"2006","journal-title":"Curr Eye Res"}],"container-title":["Burns"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305417912002367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305417912002367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T03:02:59Z","timestamp":1562122979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305417912002367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0305417912002367"],"URL":"https:\/\/doi.org\/10.1016\/j.burns.2012.07.018","relation":{},"ISSN":["0305-4179"],"issn-type":[{"value":"0305-4179","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}